Renaissance Technologies - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 73 filers reported holding ENZO BIOCHEM INC in Q2 2021. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$3,578
-28.1%
2,556,064
-5.5%
0.01%
-14.3%
Q2 2023$4,977
-26.1%
2,704,864
-2.4%
0.01%
-22.2%
Q1 2023$6,731
+67.3%
2,770,064
-1.6%
0.01%
+50.0%
Q4 2022$4,024
-99.9%
2,813,964
-3.3%
0.01%
-33.3%
Q3 2022$6,489,000
+3.9%
2,909,664
-3.5%
0.01%
+28.6%
Q2 2022$6,243,000
-28.5%
3,016,164
+0.2%
0.01%
-30.0%
Q1 2022$8,732,000
-12.1%
3,011,164
-2.7%
0.01%
-16.7%
Q4 2021$9,934,000
-12.6%
3,094,764
-3.6%
0.01%
-20.0%
Q3 2021$11,364,000
+10.0%
3,210,064
-1.5%
0.02%
+15.4%
Q2 2021$10,332,000
-10.1%
3,259,264
-2.4%
0.01%
-7.1%
Q1 2021$11,493,000
+28.2%
3,340,864
-6.1%
0.01%
+40.0%
Q4 2020$8,962,000
+18.4%
3,556,223
-0.9%
0.01%
+25.0%
Q3 2020$7,568,000
-2.5%
3,586,723
+3.5%
0.01%
+14.3%
Q2 2020$7,762,000
-7.4%
3,465,278
+4.6%
0.01%
-12.5%
Q1 2020$8,379,000
-5.0%
3,311,978
-1.2%
0.01%
+14.3%
Q4 2019$8,821,000
-25.7%
3,353,808
+1.6%
0.01%
-30.0%
Q3 2019$11,878,000
+8.4%
3,299,563
+1.5%
0.01%0.0%
Q2 2019$10,956,000
+26.0%
3,251,033
+2.1%
0.01%
+25.0%
Q1 2019$8,696,000
+1.3%
3,185,229
+3.2%
0.01%
-11.1%
Q4 2018$8,584,000
-29.7%
3,087,670
+4.2%
0.01%
-30.8%
Q3 2018$12,206,000
-61.7%
2,962,700
-50.4%
0.01%
-23.5%
Q2 2018$31,894,000
+95.5%
5,979,100
+100.8%
0.02%
-5.6%
Q1 2018$16,313,000
-14.3%
2,976,900
+27.4%
0.02%
-14.3%
Q4 2017$19,037,000
-15.0%
2,335,800
+9.3%
0.02%
-19.2%
Q3 2017$22,384,000
-2.0%
2,137,900
+3.3%
0.03%
-10.3%
Q2 2017$22,848,000
+33.7%
2,069,600
+1.3%
0.03%
+20.8%
Q1 2017$17,095,000
+25.3%
2,042,400
+3.9%
0.02%
+9.1%
Q4 2016$13,641,000
+36.9%
1,965,500
+0.4%
0.02%
+22.2%
Q3 2016$9,963,000
-10.6%
1,957,368
+4.8%
0.02%
-14.3%
Q2 2016$11,146,000
+69.0%
1,866,981
+28.8%
0.02%
+61.5%
Q1 2016$6,597,000
+17.0%
1,449,900
+15.7%
0.01%
+8.3%
Q4 2015$5,639,000
+59.8%
1,253,100
+12.6%
0.01%
+50.0%
Q3 2015$3,529,000
-1.3%
1,113,200
-5.7%
0.01%0.0%
Q2 2015$3,576,000
-0.1%
1,180,152
-2.8%
0.01%0.0%
Q1 2015$3,580,000
-14.6%
1,213,643
+28.5%
0.01%
-20.0%
Q4 2014$4,193,000
-12.3%
944,337
+1.7%
0.01%
-23.1%
Q3 2014$4,783,000
+61.6%
928,800
+64.7%
0.01%
+85.7%
Q2 2014$2,960,000
+58.9%
563,818
+25.9%
0.01%
+75.0%
Q1 2014$1,863,000
+84.6%
447,881
+29.6%
0.00%
+100.0%
Q4 2013$1,009,000
+41.1%
345,637
+21.7%
0.00%0.0%
Q3 2013$715,000
+32.9%
283,900
+9.8%
0.00%
+100.0%
Q2 2013$538,000258,5000.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2021
NameSharesValueWeighting ↓
HARBERT FUND ADVISORS, INC. 5,175,913$7,246,2785.30%
Potomac Capital Management, Inc. 1,455,000$2,037,0002.60%
TANG CAPITAL MANAGEMENT LLC 2,200,000$3,080,0000.44%
RBF Capital, LLC 250,359$350,5030.02%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$36,0000.02%
Shay Capital LLC 62,500$87,5000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 227,100$317,9400.01%
Paradigm Financial Partners, LLC 19,500$26,3250.01%
Shulman DeMeo Asset Management LLC 15,487$21,6820.01%
Renaissance Technologies 2,556,064$3,5780.01%
View complete list of ENZO BIOCHEM INC shareholders